ORIC PHARMACEUTICALS, INC.

Profile

Company Names

ORIC PHARMACEUTICALS, INC.

Addresses

240 E. GRAND AVE., 2ND FLOOR, SOUTH SAN FRANCISCO, CA 94080

Phone Numbers

(650) 388-5600

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$334,999,678.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2025-05-29 
$125,000,000.00 
$125,000,000.00 
$0.00 
Equity 
2
2024-01-23 
$125,000,000.00 
$125,000,000.00 
$0.00 
Equity 
1
2023-06-27 
$84,999,678.00 
$84,999,678.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JACOB 
M. 
CHACKO 
EXECUTIVE OFFICER, DIRECTOR
ORIC PHARMACEUTICALS, INC.
MARDI 
 
DIER 
DIRECTOR
PORTOLA PHARMACEUTICALS INC   |  ORIC PHARMACEUTICALS, INC.
MARDI 
C. 
DIER 
DIRECTOR
PRELUDE THERAPEUTICS INC   |  ORIC PHARMACEUTICALS, INC.
RICHARD 
 
HEYMAN 
DIRECTOR
METACRINE, INC.   |  YUMANITY HOLDINGS, LLC   |  VIVIDION THERAPEUTICS, INC.   |  AMUNIX PHARMACEUTICALS, INC.   |  ORIC PHARMACEUTICALS, INC.   |  ENLIVEN THERAPEUTICS, INC.   |  PELAGE PHARMACEUTICALS, INC.
STEVE 
L. 
HOERTER 
DIRECTOR
ORIC PHARMACEUTICALS, INC.
LORI 
 
KUNKEL 
DIRECTOR
TOCAGEN INC   |  MAVERICK THERAPEUTICS INC.   |  NURIX THERAPEUTICS, INC.   |  ORIC PHARMACEUTICALS, INC.
PRATIK 
 
MULTANI 
EXECUTIVE OFFICER
ORIC PHARMACEUTICALS, INC.
DOMINIC 
 
PISCITELLI 
EXECUTIVE OFFICER
ORIC PHARMACEUTICALS, INC.
ANGIE 
 
YOU 
DIRECTOR
ARAGON PHARMACEUTICALS, INC.   |  AMUNIX PHARMACEUTICALS, INC.   |  RAYZEBIO, INC.   |  ORIC PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-06-06
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-05-29 
2024-01-30
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-01-23 
2023-07-05
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-06-27 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#